Mike Wenzel

47PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersScience, technology and engineering curriculum and pedagogyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Sep 10, 2026
Cancer-Control Outcomes of Japanese Vs. German Metastatic Hormone-Sensitive Prostate Cancer Patients: A Real-World Cross-Country Comparison of Patients Undergoing Combination Therapies.

|Jul 10, 2026
Ten-year update on the European Association of Urology Robotic Section (ERUS) fellowship training for robot-assisted radical prostatectomy.

|May 06, 2025
Real world comparison of adjuvant vs. salvage radiation therapy on cancer-control outcomes after radical prostatectomy.

Mike Wenzel, Katrin Burdenski, Nikolaos Tselis

|Apr 07, 2025
Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients.

Mike Wenzel, Lena Theissen, Daniel Groener

|Jan 13, 2025
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.

Mike Wenzel, Benedikt Hoeh, Carolin Siech

|Dec 16, 2024
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.

Mike Wenzel, Benedikt Hoeh, Clara Humke

Pageof 8

Frequent Collaborators

21 joint publications

Christoph Würnschimmel

18 joint publications

Derya Tilki

8 joint publications

Claudia Collà Ruvolo

7 joint publications

Luigi Nocera